Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,501 JPY | -3.91% | -2.91% | +5.63% |
04-18 | Nxera Pharma Initiates Restricted Stock Unit Plans, Starting with Shares Worth 164 Million Yen in Total in May | MT |
04-17 | Nxera Pharma's Neuro Drug NBI-1117568 Passed Preclinical Toxicity Test | MT |